ストックスクリーナーアプリを入手
4.14
6.43%
0.25
アフターアワーズ：
4.14
前日終値:
$3.89
開ける：
$3.89
24時間の取引高:
234.84K
Relative Volume:
0.51
時価総額：
$254.26M
収益：
$45.15M
当期純損益:
$-39.23M
株価収益率:
-2.2635
EPS:
-1.829
ネットキャッシュフロー:
$-18.93M
1週間 パフォーマンス:
-11.73%
1か月 パフォーマンス:
+16.62%
6か月 パフォーマンス:
-28.62%
1年 パフォーマンス:
-17.20%
1日の値動き範囲:
$3.79
$4.23
1週間の範囲:
$3.67
$4.70
52週間の値動き範囲:
$2.20
$7.95
Trisalus Life Sciences Inc Stock (TLSI) Company Profile
名前
Trisalus Life Sciences Inc
セクター
電話
415 336 8917
住所
6272 WEST 91ST AVENUE, WESTMINSTER
Compare TLSI vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TLSI
Trisalus Life Sciences Inc
|
4.14 | 254.26M | 45.15M | -39.23M | -18.93M | -1.829 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Trisalus Life Sciences Inc Stock (TLSI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-13 | 開始されました | Lake Street | Buy |
| 2024-12-17 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-11-11 | 開始されました | ROTH MKM | Buy |
| 2024-10-25 | 開始されました | Northland Capital | Outperform |
| 2024-09-16 | 開始されました | Oppenheimer | Outperform |
| 2024-05-30 | 開始されました | Canaccord Genuity | Buy |
すべてを表示
Trisalus Life Sciences Inc (TLSI) 最新ニュース
TriSalus Life Sciences, Inc. (TLSI) reports Q1 loss, lags revenue estimates - MSN
First Light Asset Management, Mathew Arens report 10.74% stake in TriSalus (TLSI) - Stock Titan
Form 4 TriSalus Life Sciences Inc For: 6 July By Investing.com - Investing.com Canada
TriSalus (TLSI) CFO has shares withheld to cover RSU tax obligations - Stock Titan
TriSalus Life Sciences, Inc. Warrant 2023-04.08.2028 on TriSalus Life Sciences Financial Disclosures & SEC Filings - TradingView
Bronstein, Gewirtz & Grossman, LLC Encourages TriSalus Life Scien - The National Law Review
TriSalus Life Sciences (TLSI) Stock Analysis Report | Financials & Insights - Benzinga
TriSalus (TLSI) CEO Mary Szela acquires 3,990 ESPP shares, now holds 1.08M - Stock Titan
TriSalus Life Sciences (TLSI) CCO acquires 561 ESPP shares - Stock Titan
Price to earnings forward of TriSalus Life Sciences, Inc. – NASDAQ:TLSI - TradingView
Form 4 TriSalus Life Sciences Inc For: 29 June By Investing.com - Investing.com Canada
TriSalus Life Sciences (TLSI) CMO awarded RSUs and 120,000-share option grant - Stock Titan
TriSalus (TLSI) CMO discloses common stock and option holdings in Form 3 - Stock Titan
TriSalus Life Sciences, Inc.(NasdaqGM:TLSI) dropped from Russell Small Cap Comp Value Benchmark - marketscreener.com
TriSalus Life Sciences, Inc.(NasdaqGM: TLSI) dropped from Russell 3000 Value Benchmark - marketscreener.com
TriSalus Life Sciences, Inc.(NasdaqGM: TLSI) dropped from Russell 2500 Value Benchmark - marketscreener.com
TriSalus Life Sciences, Inc.(NasdaqGM:TLSI) dropped from Russell Microcap Value Benchmark Index - marketscreener.com
TriSalus Life Sciences, Inc.(NasdaqGM: TLSI) dropped from Russell 2000 Value Benchmark - marketscreener.com
TriSalus Life Sciences, Inc. Actuals & Estimates (NASDAQ:TLSI) - TradingView
TLSI Forecast — Price Target — Prediction for 2027 - TradingView
Canaccord reiterates TriSalus stock Buy rating after KOL event - Investing.com UK
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc.TLSI - PR Newswire
Canaccord reiterates TriSalus stock Buy rating after KOL event By Investing.com - Investing.com Australia
CCORF Maintains TriSalus Life Sciences(TLSI.US) With Buy Rating, Maintains Target Price $7 - Moomoo
TriSalus Life Sciences (TLSI) Gains 3.23% as Shares Test Resistance at $4.37Ichimoku Kumo Twist - dars.gov.et
TriSalus Life Sciences Inc (TLSIW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
TLSI News | TRISALUS LIFE SCIENCES INC (NASDAQ:TLSI) - ChartMill
TriSalus Life Sciences Inc (TLSIW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
TriSalus Life Sciences Inc (TLSIW) Institutional Confidence - TradingKey
TriSalus Life Sciences Inc (TLSIW) Valuation: PE, PB & Fair Value Analysis - TradingKey
TriSalus Life Sciences Inc (TLSIW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
TriSalus Life Sciences Inc (TLSI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
TriSalus Life Sciences Warrants (TLSIW) Hold Ground at $0.65 – Key Levels in FocusPrice Surge Stocks - dars.gov.et
TriSalus Life Sciences Inc (TLSI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
TriSalus Life Sciences Inc (TLSI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
TriSalus Life Sciences Inc (TLSI) Institutional Confidence - TradingKey
TriSalus Life Sciences Inc (TLSI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
TriSalus Life Sciences Inc (TLSI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
TriSalus Life Sciences Inc (TLSI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TriSalus Life Sciences Inc (TLSI) Valuation: PE, PB & Fair Value Analysis - TradingKey
TriSalus Life Sciences Inc (TLSI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TriSalus Life Sciences Inc (TLSIW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TriSalus Life Sciences Inc (TLSIW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TriSalus Life Sciences Inc (TLSIW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
TLSI Investors Have Opportunity to Join TriSalus Life Sciences, Inc. Fraud Investigation with the Schall Law Firm - GlobeNewswire
Richard Marshall Accepts New Role at TriSalus Life Sciences - Medical Product Outsourcing
TriSalus Life Sciences (TLSI) Q1 2026 Earnings: Surprise Profit Beats Estimates, Shares Jump 11.4%Guidance Accuracy Score - dars.gov.et
TriSalus Life Sciences Warrants (TLSIW) Hold Steady Near Support in Quiet TradingAndrews Pitchfork - newsline.com
TLSI Q1 2026 Earnings: EPS Surprise of 118.86% Drives Stock HigherAnalyst Drop Coverage - newsline.com
TriSalus Life Sciences (TLSI) Q1 2026 Earnings: Surprise Profitability as EPS Beats Estimates by 118.86% - newsline.com
TriSalus Life Sciences (TLSI) Gains 2.88% as Stock Approaches Key Resistance LevelWave Extension - newsline.com
Trisalus Life Sciences Inc (TLSI) 財務データ
収益
当期純利益
現金流量
EPS
2.36%
大文字化:
|
ボリューム (24 時間):